Advertisement
Research Article

IL-17A and IL-2-Expanded Regulatory T Cells Cooperate to Inhibit Th1-Mediated Rejection of MHC II Disparate Skin Grafts

  • Benoît Vokaer equal contributor mail,

    equal contributor Contributed equally to this work with: Benoît Vokaer, Louis-Marie Charbonnier

    bvokaer@ulb.ac.be (BV); alemoine@ulb.ac.be (ALM)

    Affiliation: Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium

    X
  • Louis-Marie Charbonnier equal contributor,

    equal contributor Contributed equally to this work with: Benoît Vokaer, Louis-Marie Charbonnier

    Affiliation: Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium

    X
  • Philippe H. Lemaître,

    Affiliation: Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium

    X
  • Chloé Spilleboudt,

    Affiliation: Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium

    X
  • Alain Le Moine mail

    bvokaer@ulb.ac.be (BV); alemoine@ulb.ac.be (ALM)

    Affiliation: Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium

    X
  • Published: October 11, 2013
  • DOI: 10.1371/journal.pone.0076040

About the Authors

Benoît Vokaer, Louis-Marie Charbonnier, Philippe H. Lemaître, Chloé Spilleboudt, Alain Le Moine
Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium

Corresponding Authors

Competing Interests

This study was partly funded by GlaxoSmithKline Biologicals. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceived and designed the experiments: BV LMC. Performed the experiments: BV LMC PL CS. Analyzed the data: BV LMC ALM. Contributed reagents/materials/analysis tools: BV LMC PL CS ALM. Wrote the paper: BV LMC ALM. Made the figures: BV LMC. Designed and supervised research: ALM.